Summary: | Our previous research proved that benzenesulfonylguanidine derivatives display significant cytotoxic activity against human cancer cells. Here, we describe new 1-(2-alkylthio-4-chloro-5-methylbenzenesulfonyl)guanidines with cytotoxic activity against HCT-116 and MCF-7 cells. The planned derivatives were obtained by a two-step synthesis. The starting substrates were 1-(2-alkylthio-4-chloro-5-methyl)benzenesulfonyl)-3-aminoguanidines <b>1</b>–<b>4,</b> which were transformed into 1-(2-alkylthio-4-chloro-5-methylbenzenesulfonyl)-3-[(2-chloroacetyl)amino]guanidines <b>5–8</b> by a reaction with chloroacetyl chloride. In the next step, the derivatives <b>5</b>–<b>8</b> were reacted with potassium thiocyanate, yielding 1-(2-alkylthio-4-chloro-5-methylbenzenesulfonyl)-3-(2-imino-4-oxothiazolidine-3-yl)guanidines <b>9</b>–<b>12</b>. The synthesized derivatives <b>5</b>–<b>12</b> were evaluated in vitro by MTT assays for their activity against three human cancer cell lines: colon cancer HCT-116, breast cancer MCF-7, and cervical cancer HeLa. The activity against non-cancerous human epidermal keratinocyte line HaCaT was also examined. The data indicate that compounds <b>5</b>–<b>8</b> inhibit the growth of cancer cells more strongly than derivatives <b>9</b>–<b>12</b>. The selective cytotoxic effect against HCT-116 cells was found for benzenesulfonylguanidine <b>6</b> containing a 2-(trifluoromethyl)benzylthio group at position two of the benzenesulfonyl scaffold. The IC<sub>50</sub> value was 13 μM, while IC<sub>50</sub> for HaCaT cells, it was 48 μM. Good selectivity was also observed for compound <b>7</b>, with a 2-chloromethylbenzylthio substituent, against HCT-116 and MCF-7 cells (IC<sub>50</sub> = 12 and 19 μM, respectively, for HCT-116 and MCF-7 cells, IC<sub>50</sub> = 47 μM for HaCaT cells). Among compounds <b>9</b>–<b>12</b>, only compound <b>9</b> showed moderate but selective cytotoxicity against MCF-7 cells, with IC<sub>50</sub> = 18 μM compared with IC<sub>50</sub> = 54 μM for HaCaT cells.
|